Federal contract award
36C26024F0421
ERDAFITINIB (BALVERSA) 4MG TABLETS (56 TAB BTL).
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | 260-NETWORK CONTRACT OFFICE 20 (36C260) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0217 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | $0 |
| Potential contract value / ceiling | $0 |
| Start date | Jun 20, 2024 |
| Current end date | Jun 19, 2025 |
| Potential end date | Jun 19, 2025 |
| Latest award activity | Nov 13, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Nov 13, 2024 | P00001 | $-211.7K | ERDAFITINIB (BALVERSA) 4MG TABLETS (56 TAB BTL). |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.